HIGHLIGHTS
- who: M. Jansson from the Department of Public Health and Clinical Medicine, Umeu00e5 have published the paper: Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation, in the Journal: (JOURNAL) of December/31,/2017
- what: The aim of this study was to compare effectiveness and safety between reduced dose DOACs and high TTR warfarin treatment (TTR u2265 70%) in NVAF. The study was conducted as a meta-analysis by subgroups in randomized controlled trials (RCTs) and therefore had heterogeneity in studied populations. The study shows no . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.